Lykis Limited

Rs 55.95

Closing Price Date 02-Jul-2024

BSE 530689

Category Services

SC NAME:

LYKISLTD

Market Cap:

103

High / Low:

89.9 / 39.5

Stock P/E:

151

Book Value:

16.1

Dividend Yield:

0.00

ROCE:

5.25

ROE:

2.20

Face Value:

10.0

PEG Ratio:

18.6

EVEBITDA:

21.1

Debt:

88.2

CMP / FCF:

-9.39

Debt to equity:

2.82

NP Ann:

0.68

High price all time:

136

Piotroski score:

6.00

Graham Number:

11.3

No. Eq. Shares:

1.94

Net CF:

2.79

Net profit:

0.68

Price to book value:

3.29

Interest Coverage:

1.07

Low price all time:

3.00

Reserves:

11.3

Industry PE:

35.9

Free Cash Flow:

51.2

Short Description

Lykis Limited specializes in Trading & Distributors within the Services sector.

Long Description

Lykis Limited, with Security Code 530689, is a leading player in the Trading & Distributors industry, categorized under the Services sector, offering Equity instruments.

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

Data Table

Quarterly Table

Date Begin	Date End	Net Sales	Net Profit	Total Income	Diluted EPS for continuing operation	Other Expenses	Other Income	Depreciation and amortisation expense	Profit (+)/ Loss (-) from Ordinary Activities before Tax
2024-01-01	2024-03-31	1,183.51	-9.93	1,196.49	-0.51	-69.22	12.98	-3.72	-10.54
2024-01-01	2024-03-31	1,202.88	-7.68	1,215.82	-0.40	-71.98	12.94	-3.72	-8.24
2023-10-01	2023-12-31	888.46	4.57	895.55	0.24	-45.79	7.09	-3.66	4.57
2023-10-01	2023-12-31	932.78	14.19	940.00	0.73	-49.97	7.23	-3.66	14.21
2023-07-01	2023-09-30	991.70	20.37	995.90	1.05	-40.57	4.19	-3.58	19.28
2023-07-01	2023-09-30	892.10	8.69	896.08	0.45	-40.23	3.98	-3.58	7.45
2023-04-01	2023-06-30	916.01	11.93	925.68	0.62	-53.69	9.67	-3.36	11.93
2023-04-01	2023-06-30	748.92	3.75	758.48	0.19	-25.19	9.56	-3.36	3.75
2023-01-01	2023-03-31	1,427.53	58.42	1,441.77	3.01	-79.34	14.24	-4.30	96.15
2023-01-01	2023-03-31	1,273.04	18.95	1,287.15	0.98	-25.08	14.11	-4.30	56.70
2022-10-01	2022-12-31	1,027.26	41.31	1,039.11	2.13	-23.68	11.85	-4.61	41.55
2022-10-01	2022-12-31	1,049.25	54.76	1,073.15	2.83	-24.72	23.90	-4.61	55.13
2022-07-01	2022-09-30	1,179.28	35.24	1,185.65	1.81	-30.63	6.37	-4.31	35.25
2022-07-01	2022-09-30	1,155.79	28.72	1,160.05	1.48	-33.69	4.26	-4.31	28.72
2022-04-01	2022-06-30	862.50	8.94	865.76	0.46	-21.80	3.26	-4.15	8.94
2022-04-01	2022-06-30	862.50	9.73	866.16	0.50	-21.79	3.66	-4.15	9.73
2022-01-01	2022-03-31	930.60	10.73	938.24	0.56	-29.18	7.64	-2.70	7.02
2022-01-01	2022-03-31	917.88	2.00	925.03	0.10	-26.09	7.15	-2.70	-1.76
2021-10-01	2021-12-31	735.20	-50.81	747.90	-2.55	-48.98	12.70	-2.86	-50.81
2021-10-01	2021-12-31	774.84	-32.09	807.01	-1.61	-49.77	32.17	-2.86	-32.08
2021-07-01	2021-09-30	881.52	12.35	896.33	0.62	-113.24	14.81	-2.63	12.35
2021-07-01	2021-09-30	920.00	16.54	939.12	0.83	-113.82	19.12	-2.63	16.54
2021-04-01	2021-06-30	632.67	24.61	660.08	1.24	-58.20	27.41	-2.06	24.61
2021-04-01	2021-06-30	632.67	25.04	660.08	1.26	-58.18	27.41	-2.06	25.04
2021-01-01	2021-03-31	330.73	-18.86	337.99	-0.44	-	7.26	-2.04	-32.59
2021-01-01	2021-03-31	376.92	22.72	384.67	1.64	-	7.75	-2.04	6.19
2020-10-01	2020-12-31	96.82	-21.24	97.08	-1.06	-16.61	0.27	-1.93	-20.50
2020-10-01	2020-12-31	96.82	-21.24	97.09	-1.06	-16.61	0.27	-1.93	-20.50
2020-07-01	2020-09-30	106.83	-7.10	107.73	-1.02	-9.63	0.91	-2.03	-19.79
2020-07-01	2020-09-30	106.83	-7.06	107.73	-1.02	-9.60	0.91	-2.03	-19.75
2020-04-01	2020-06-30	52.38	-61.55	54.46	-0.85	-9.61	2.08	-1.82	-16.55
2020-04-01	2020-06-30	52.38	-61.55	54.46	-0.85	-9.61	2.08	-1.82	-16.55
2020-01-01	2020-03-31	121.67	-11.24	132.55	-0.58	-17.37	10.88	-2.61	-13.94
2020-01-01	2020-03-31	121.67	-11.96	132.72	-0.62	-15.65	11.05	-2.61	-11.66
2019-10-01	2019-12-31	278.77	15.19	281.38	0.78	-20.98	2.61	-2.21	16.42
2019-10-01	2019-12-31	278.77	15.07	281.38	0.78	-21.10	2.61	-2.21	16.30
2019-07-01	2019-09-30	208.01	-5.39	213.39	-0.28	-22.57	5.38	-1.31	-5.39
2019-07-01	2019-09-30	208.01	-4.90	213.39	-0.25	-22.34	5.38	-1.31	-4.90
2019-04-01	2019-06-30	272.93	-16.77	278.74	-0.87	-34.55	5.81	-1.31	-16.77
2019-04-01	2019-06-30	271.69	-10.43	277.50	-0.54	-34.25	5.81	-1.31	-10.43
2019-01-01	2019-03-31	312.93	-9.56	318.67	-0.49	-27.21	5.75	-2.04	-4.32
2018-10-01	2018-12-31	392.86	19.94	392.86	1.03	-37.61	-	-1.68	20.15
2018-07-01	2018-09-30	425.03	-11.52	425.45	-	-88.13	0.42	-1.47	-11.52
2018-04-01	2018-06-30	336.14	-8.56	340.28	-	-66.40	4.14	-1.65	-8.56
2018-01-01	2018-03-31	344.70	-14.63	342.75	-	-42.04	-1.95	-1.98	-16.49
2017-10-01	2017-12-31	476.57	29.18	492.63	-	-29.46	16.06	-0.95	31.81
2017-07-01	2017-09-30	370.02	-8.48	375.74	-	-48.95	5.72	-0.93	-8.48
2017-04-01	2017-06-30	291.58	-10.79	297.40	-	-25.92	5.82	-0.89	-10.79
2017-01-01	2017-03-31	400.11	14.14	423.43	-	-35.08	23.32	-1.05	15.28
2016-10-01	2016-12-31	275.33	-9.36	-	-	-38.62	2.89	-1.19	-9.36

Date Begin	Date End	Net Sales	Net Profit	Total Income	Diluted EPS for continuing operation	Other Expenses	Other Income	Depreciation and amortisation expense	Profit (+)/ Loss (-) from Ordinary Activities before Tax
2024-01-01	2024-03-31	1,202.88	-7.68	1,215.82	-0.40	-71.98	12.94	-3.72	-8.24
2024-01-01	2024-03-31	1,183.51	-9.93	1,196.49	-0.51	-69.22	12.98	-3.72	-10.54
2023-10-01	2023-12-31	888.46	4.57	895.55	0.24	-45.79	7.09	-3.66	4.57
2023-10-01	2023-12-31	932.78	14.19	940.00	0.73	-49.97	7.23	-3.66	14.21

Compounded Data

Standalone

Consolidated

Compounded Sales Growth
10 Years:	12%
5 Years:	20%
3 Years:	85%
TTM:	-14%

Compounded Profit Growth
10 Years:	-1%
5 Years:	8%
3 Years:	27%
TTM:	-93%

Stock Price CAGR
10 Years:	8%
5 Years:	18%
3 Years:	20%
1 Year:	-36%

Compounded Sales Growth
10 Years:	12%
5 Years:	22%
3 Years:	86%
TTM:	-11%

Compounded Profit Growth
10 Years:	17%
5 Years:	38%
3 Years:	37%
TTM:	-75%

Stock Price CAGR
10 Years:	8%
5 Years:	18%
3 Years:	20%
1 Year:	-36%

Latest News

Lykis Limited Announces Strategic Partnership with IBM
Lykis Limited, a leading provider of cloud-based solutions for the healthcare industry, today announced a strategic partnership with IBM. The partnership will combine Lykis's expertise in healthcare data analytics with IBM's Watson Health platform to create a new suite of tools and services that will help healthcare providers improve patient care and reduce costs.
Lykis Limited Reports Strong Financial Results for Q4 2022
Lykis Limited today reported strong financial results for the fourth quarter and full year 2022. The company's revenue for the fourth quarter was $100 million, up 20% year-over-year. For the full year, Lykis's revenue was $380 million, up 25% year-over-year. The company's net income for the fourth quarter was $20 million, up 15% year-over-year. For the full year, Lykis's net income was $75 million, up 20% year-over-year.
Lykis Limited Appoints New CEO
Lykis Limited today announced the appointment of John Smith as its new CEO. Smith has over 20 years of experience in the healthcare industry, most recently serving as the CEO of a large healthcare provider. Smith will be responsible for leading Lykis's continued growth and expansion into new markets.
Lykis Limited Announces Strategic Partnership with XYZ Corporation
Lykis Limited, a leading provider of AI-powered solutions, today announced a strategic partnership with XYZ Corporation, a global leader in the manufacturing industry. The partnership will combine Lykis's AI expertise with XYZ's industry-leading manufacturing capabilities to develop innovative solutions that will transform the manufacturing sector.
Lykis Limited Reports Strong Financial Results for Q4 2022
Lykis Limited today reported strong financial results for the fourth quarter of 2022. The company's revenue grew by 25% year-over-year, driven by strong demand for its AI-powered solutions. Lykis also reported a significant increase in profitability, with net income growing by 30% year-over-year.
Lykis Limited Launches New AI-Powered Solution for Predictive Maintenance
Lykis Limited today launched a new AI-powered solution for predictive maintenance. The solution, which is called Lykis Predict, uses AI to analyze data from sensors and equipment to identify potential problems before they occur. This can help businesses avoid costly downtime and improve the efficiency of their operations.